The Extraordinary General Assembly of the Egyptian International Pharmaceutical Industries Company (EIPICO) approved increasing the authorized capital from EGP 1.5 billion to EGP 6 billion.

This came during the meeting held on Saturday, December 14, 2024, at the company's headquarters in the city of Tenth of Ramadan

The Assembly also approved increasing the issued capital from EGP 1.48 billion to EGP 1.68 billion, an increase of EGP 200 million distributed over 20 million shares based on the fair value of EGP 50 per share divided (EGP 10 nominal value and EGP 40 issuance premium) without issuance expenses.

All the agenda items published in the invitation to convene , were discussed & approved.

Dr. Ahmed Kelani performed a film, during the meeting, showing the accomplishment of EIPICO 3 factory construction & announcing the start of production lines validation.

You can watch the film through this link:

Eventually, the shareholders participating in the meeting praised the efforts of Dr. Ahmed Kelani , EIPICO Chairman and Managing Director, and members of the Board of Directors, expressing their appreciation for the great achievements accomplished by the company, in all fields during the past few years in light of unprecedented challenges regionally and globally